BSE filing, NSE: PATIDAR. Summary written from the filing by ALFA Finder's alert engine.
Patidar Buildcon Ltd: key numbers
- Share price
- ₹6.40
- Market cap
- ₹3.52 Cr
- Revenue (annual)
- ₹0.34 Cr
- Net profit (annual)
- ₹-0.23 Cr
- P/E (TTM)
- -16.1×Sector 34.0×
- Promoter holding
- 20.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Patidar Buildcon Ltd
All →Patidar Buildcon Board Meeting Date
Patidar Buildcon will hold a board meeting on 5 November 2026 to approve unaudited Q2 results for the quarter ended 30 September 2026. The trading window stays closed until 7 November 2026.
Patidar Buildcon Annual General Meeting
Patidar Buildcon Ltd conducted its 37th Annual General Meeting on September 28, 2026. Shareholders approved the audited financial statements and the reappointment of Mr. Dhirajlal Patel as Director.
Patidar Buildcon Annual Report
Patidar Buildcon Ltd filed its Annual Report for FY 2025-26. The company also announced its 37th Annual General Meeting scheduled for September 28, 2026.
Patidar Buildcon Annual General Meeting
Patidar Buildcon Ltd announced book closure from September 22 to September 28, 2026, for its 37th Annual General Meeting scheduled on September 28, 2026.
Patidar Buildcon Q1 FY27 Results: Net Profit ₹0 Cr
Patidar Buildcon Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Patidar Buildcon Board Meeting Outcome
Patidar Buildcon Ltd approved its unaudited financial results for the quarter ended June 30, 2026. It also approved the notice for the upcoming Annual General Meeting.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.